Drug Discovery 2022: driving the next life science revolution

Dr Jelena Aleksic

Dr Jelena Aleksic
Dr Jelena Aleksic

Profile of Dr Jelena Aleksic

Jelena is a geneticist and serial entrepreneur, passionate about the potential of biotechnology to improve patients’ lives. She is co-founder and CBO of PharmEnable, an AI drug discovery company mapping unexplored chemical space to deliver the next generation of innovative medicines. The PharmEnable approach integrates advanced medicinal chemistry expertise and cutting edge AI/computational methods to unlock challenging targets and develop complex and 3-dimensional small molecule drugs.
As a serial entrepreneur and former CEO, Jelena brings significant commercial and business development experience and is leading PharmEnable’s business efforts. She was the founder and CEO of GeneAdviser, an online marketplace for clinical genetic tests, now owned by the UK NHS. She also founded a life science and business strategy consultancy, SparkBio Ltd, and was one of the founding directors of the Cambridge Rare Disease Network. She completed her PhD at the University of Cambridge in Genomics and Computational Biology and has an academic background in genome regulation and rare diseases.


Please login to send a Private Message

Hosted By


The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'